Thermo Fisher Scientific to Acquire Electron Microscopy Firm FEI for $4.2B | GenomeWeb

NEW YORK (GenomeWeb) – Thermo Fisher Scientific announced today that it will acquire electron microscopy firm FEI Company for $4.2 billion in cash, or $107.50 per share.

Thermo Fisher President and CEO Marc Casper said in a statement that his company will use FEI's technology to complement its existing mass spectrometry business, particularly in its work on structural proteins and biopharmaceuticals.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.